-
-
-
-
-
-
-
Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand
-
-
-
-
-
-
-
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
-
-
-
-
-
-
-
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent Developments
-
-
-
-
-
-
-
Avid Bioservices, Inc. Announces Pricing of $125 Million Offering of Exchangeable Senior Notes
-
-
-
-
-
-
-
Pre-Open Movers 09/11: (IVTY) (CDMO) (IDTI) Higher; (USAT) (FRAN) (SONO) Lower (more...)
-
-
-
-
-
-
-
Avid Bioservices (CDMO), Oncologie Enter Asset Assignment and Purchase Agreement for Avid's PS-Targeting Program Including Bavituximab
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

